Zapanta, J.B. and Gorospe, C. 2025. Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer after Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report. Asian Pacific Journal of Cancer Care. 10, 3 (Jul. 2025), 989-992. DOI:https://doi.org/10.31557/apjcc.2025.10.3.989-992.